Percentages show how often each reaction appears relative to total reports for fludarabine.
2 Cytokine Release Syndrome 6.7% 2,813
3 Drug Ineffective 6.5% 2,729
5 Febrile Neutropenia 6.1% 2,558
6 Product Use In Unapproved Indication 5.2% 2,169
8 Cytomegalovirus Infection 3.5% 1,466
9 Thrombocytopenia 3.3% 1,392
11 Mucosal Inflammation 2.9% 1,225
14 Acute Graft Versus Host Disease 2.8% 1,183
These are voluntary reports and do not establish that fludarabine caused these reactions.
Report severity
97.8% Serious 40,874 reports
29.5% Hospitalizations 12,341 reports
31.8% Fatal 13,271 reports
Seriousness is determined by the reporter, not by OpenClaim.
Fludarabine drug interactions
Other drugs that appear in adverse event reports alongside fludarabine. Drugs flagged as a suspected cause appear in the first column. Drugs taken at the same time but not suspected appear in the second.
Also suspected
1 Cyclophosphamide 37.7% 15,751
12 Vincristine-sulfate 7.1% 2,981
15 Doxorubicin-hydrochloride 6.0% 2,523
Taken alongside
1 Cyclophosphamide 14.5% 6,063
5 Sulfamethoxazole 6.2% 2,575
13 Methylprednisolone 4.6% 1,943
Co-occurrence in adverse event reports does not establish a drug interaction. Patients often take multiple medications, and these lists reflect prescribing patterns rather than causal relationships. Consult a healthcare provider about potential drug interactions.
Who reports fludarabine side effects
30.8% of fludarabine adverse event reports involve female patients and 45.7% involve male patients. The largest age group is adult at 54%. These figures reflect who reports side effects, not underlying risk.
Sex
Female 30.8%
Male 45.7%
Unknown 23.5%
Age group
< 2 4.7%
2–11 13.6%
12–17 7.1%
18–64 54.5%
65+ 20.2%
What is fludarabine used for
Conditions and purposes for which patients were taking fludarabine when the adverse event was reported.
Activated Pi3 Kinase Delta Syndrome Acute Biphenotypic Leukaemia Acute Graft Versus Host Disease Acute Haemorrhagic Leukoencephalitis Acute Leukaemia Acute Leukemia Acute Lymphocytic Leukaemia Acute Lymphocytic Leukaemia (in Remission) Acute Lymphocytic Leukaemia Recurrent Acute Lymphocytic Leukaemia Refractory Acute Megakaryocytic Leukaemia Acute Monocytic Leukaemia Acute Monocytic Leukaemia (in Remission) Acute Myeloid Leukaemia Acute Myeloid Leukaemia (in Remission)
Showing 15 of 903 indications
ACTIVATED PI3 KINASE DELTA SYNDROME ACUTE BIPHENOTYPIC LEUKAEMIA ACUTE GRAFT VERSUS HOST DISEASE ACUTE HAEMORRHAGIC LEUKOENCEPHALITIS ACUTE LEUKAEMIA ACUTE LEUKEMIA ACUTE LYMPHOCYTIC LEUKAEMIA ACUTE LYMPHOCYTIC LEUKAEMIA (IN REMISSION) ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT ACUTE LYMPHOCYTIC LEUKAEMIA REFRACTORY ACUTE MEGAKARYOCYTIC LEUKAEMIA ACUTE MONOCYTIC LEUKAEMIA ACUTE MONOCYTIC LEUKAEMIA (IN REMISSION) ACUTE MYELOID LEUKAEMIA ACUTE MYELOID LEUKAEMIA (IN REMISSION) ACUTE MYELOID LEUKAEMIA RECURRENT ACUTE MYELOID LEUKAEMIA REFRACTORY ACUTE MYELOID LEUKEMIA ACUTE MYELOMONOCYTIC LEUKAEMIA ACUTE PROMYELOCYTIC LEUKAEMIA ADENOSQUAMOUS CARCINOMA OF THE CERVIX ADRENOLEUKODYSTROPHY ADULT T-CELL LYMPHOMA/LEUKAEMIA ADULT T-CELL LYMPHOMA/LEUKAEMIA STAGE IV ALLOGENIC BONE MARROW TRANSPLANTATION THERAPY ALLOGENIC STEM CELL TRANSPLANTATION ALVEOLAR RHABDOMYOSARCOMA ANAEMIA ANAEMIA HAEMOLYTIC AUTOIMMUNE ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES ANGINA PECTORIS ANGIOCENTRIC LYMPHOMA ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA ANGIOSARCOMA ANTIDEPRESSANT THERAPY ANTIFUNGAL PROPHYLAXIS APLASIA PURE RED CELL APLASTIC ANAEMIA ATYPICAL MYCOBACTERIAL INFECTION AUTOIMMUNE HAEMOLYTIC ANAEMIA AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME AUTOLOGOUS BONE MARROW TRANSPLANTATION THERAPY AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANT AUTOSOMAL CHROMOSOME ANOMALY Acquired Von Willebrand^s disease Acute biphenotypic leukaemia Acute erythroid leukaemia Acute graft versus host disease Acute graft versus host disease in skin Acute leukaemia Acute lymphocytic leukaemia Acute lymphocytic leukaemia recurrent Acute lymphocytic leukaemia refractory Acute megakaryocytic leukaemia Acute monocytic leukaemia Acute myeloid leukaemia Acute myeloid leukaemia (in remission) Acute myeloid leukaemia recurrent Acute myeloid leukaemia refractory Acute myelomonocytic leukaemia Acute promyelocytic leukaemia Acute undifferentiated leukaemia Adenocarcinoma Adenocarcinoma metastatic Adenocarcinoma of the cervix Adrenal gland cancer metastatic Adrenoleukodystrophy Adult T-cell lymphoma/leukaemia Adult T-cell lymphoma/leukaemia stage IV Allogenic bone marrow transplantation therapy Allogenic stem cell transplantation Alpha-mannosidosis Alveolar rhabdomyosarcoma Amyloidosis Anal neoplasm Anaphylactic transfusion reaction Anaplastic large cell lymphoma T- and null-cell types Anaplastic large-cell lymphoma Anaplastic thyroid cancer Angioimmunoblastic T-cell lymphoma Antifungal prophylaxis Antisynthetase syndrome Antiviral prophylaxis Aplastic anaemia Aspergillus infection Atrial fibrillation Atypical teratoid/rhabdoid tumour of CNS Autoimmune haemolytic anaemia Autoimmune neutropenia Autoinflammatory disease Autologous haematopoietic stem cell transplant B PRECURSOR TYPE ACUTE LEUKAEMIA B precursor type acute leukaemia B-CELL CHRONIC LYMPHOCYTIC LEUKAEMIA B-CELL DEPLETION THERAPY B-CELL LYMPHOMA B-CELL LYMPHOMA RECURRENT B-CELL LYMPHOMA REFRACTORY B-CELL LYMPHOMA STAGE III B-CELL LYMPHOMA STAGE IV B-CELL PROLYMPHOCYTIC LEUKAEMIA B-CELL SMALL LYMPHOCYTIC LYMPHOMA B-CELL SMALL LYMPHOCYTIC LYMPHOMA RECURRENT B-CELL SMALL LYMPHOCYTIC LYMPHOMA REFRACTORY B-CELL SMALL LYMPHOCYTIC LYMPHOMA STAGE II B-CELL SMALL LYMPHOCYTIC LYMPHOMA STAGE IV B-CELL TYPE ACUTE LEUKAEMIA B-CELL UNCLASSIFIABLE LYMPHOMA LOW GRADE B-LYMPHOCYTE COUNT DECREASED B-cell depletion therapy B-cell lymphoma B-cell lymphoma recurrent B-cell lymphoma refractory B-cell lymphoma stage IV B-cell small lymphocytic lymphoma B-cell type acute leukaemia BING-NEEL SYNDROME BLAST CRISIS IN MYELOGENOUS LEUKAEMIA BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASIA BLOOD DISORDER BONE CANCER BONE GRAFT BONE MARROW CONDITIONING REGIMEN BONE MARROW FAILURE BONE MARROW TRANSPLANT BRAIN SARCOMA BREAST CANCER BREAST CANCER METASTATIC BREAST CANCER STAGE II BRONCHOALVEOLAR LAVAGE BURKITT'S LYMPHOMA BURKITT^S LEUKAEMIA BURKITT^S LYMPHOMA BURKITT^S LYMPHOMA STAGE IV Behcet^s syndrome Bing-Neel syndrome Blast cell crisis Blast crisis in myelogenous leukaemia Blastic plasmacytoid dendritic cell neoplasia Blood creatine phosphokinase Bone graft Bone marrow conditioning regimen Bone marrow disorder Bone marrow failure Bone marrow transplant Brain sarcoma Breast cancer Bronchopulmonary aspergillosis Burkitt^s leukaemia Burkitt^s lymphoma Burkitt^s lymphoma refractory Burkitt^s lymphoma stage IV CARDIOVASCULAR DISORDER CARTILAGE-HAIR HYPOPLASIA CD4 LYMPHOCYTES DECREASED CENTRAL NERVOUS SYSTEM LEUKAEMIA CENTRAL NERVOUS SYSTEM LYMPHOMA CERVIX CANCER METASTATIC CERVIX CARCINOMA CERVIX CARCINOMA STAGE I CERVIX CARCINOMA STAGE II CHEMOTHERAPY CHEMOTHERAPY MULTIPLE AGENTS SYSTEMIC CHLOROMA CHOLANGITIS SCLEROSING CHROMOSOMAL DELETION CHROMOSOME ANALYSIS ABNORMAL CHRONIC GRAFT VERSUS HOST DISEASE CHRONIC GRAFT VERSUS HOST DISEASE IN INTESTINE CHRONIC GRANULOMATOUS DISEASE CHRONIC LEUKAEMIA CHRONIC LYMPHOCYTIC LEUKAEMIA CHRONIC LYMPHOCYTIC LEUKAEMIA RECURRENT CHRONIC LYMPHOCYTIC LEUKAEMIA REFRACTORY CHRONIC LYMPHOCYTIC LEUKAEMIA STAGE 0 CHRONIC LYMPHOCYTIC LEUKAEMIA STAGE 1 CHRONIC LYMPHOCYTIC LEUKAEMIA STAGE 2 CHRONIC LYMPHOCYTIC LEUKAEMIA STAGE 3 CHRONIC LYMPHOCYTIC LEUKAEMIA STAGE 4 CHRONIC LYMPHOCYTIC LEUKAEMIA TRANSFORMATION CHRONIC LYMPHOCYTIC LEUKEMIA CHRONIC LYMPHOID LEUKAEMIA CHRONIC LYMPHOID LEUKEMIA CHRONIC MYELOID LEUKAEMIA CHRONIC MYELOID LEUKAEMIA RECURRENT CHRONIC MYELOID LEUKAEMIA TRANSFORMATION CHRONIC MYELOMONOCYTIC LEUKAEMIA CLL COELIAC DISEASE COLD TYPE HAEMOLYTIC ANAEMIA COLON CANCER COLONY STIMULATING FACTOR THERAPY COLORECTAL CANCER COMBINED IMMUNODEFICIENCY COMPOSITE LYMPHOMA CONGENITAL ANAEMIA CONGENITAL APLASTIC ANAEMIA CONGENITAL DISORDER OF GLYCOSYLATION CONGENITAL DYSERYTHROPOIETIC ANAEMIA CONGENITAL DYSKERATOSIS CONGENITAL ECTODERMAL DYSPLASIA CONGENITAL TERATOMA CORD BLOOD TRANSPLANT THERAPY CROHN^S DISEASE CRYOGLOBULINAEMIA CRYPTOSPORIDIOSIS INFECTION CUTANEOUS T-CELL LYMPHOMA CUTANEOUS T-CELL LYMPHOMA REFRACTORY CYTOGENETIC ABNORMALITY CYTOMEGALOVIRUS CHORIORETINITIS CYTOMEGALOVIRUS INFECTION CYTOMEGALOVIRUS VIRAEMIA CYTOPENIA Cardiac tamponade Cardiovascular deconditioning Central nervous system leukaemia Central nervous system lymphoma Cerebrovascular disorder Cervix cancer metastatic Cervix carcinoma Cervix carcinoma recurrent Chediak-Higashi syndrome Chemotherapy Chemotherapy side effect prophylaxis Chemotherapy toxicity attenuation Chloroma Cholangitis sclerosing Chronic active Epstein-Barr virus infection Chronic graft versus host disease Chronic graft versus host disease oral Chronic granulomatous disease Chronic hepatic failure Chronic inflammatory demyelinating polyradiculoneuropathy Chronic leukaemia Chronic lymphocytic leukaemia Chronic lymphocytic leukaemia recurrent Chronic lymphocytic leukaemia refractory Chronic lymphocytic leukaemia stage 1 Chronic lymphocytic leukaemia stage 2 Chronic lymphocytic leukaemia stage 3 Chronic lymphocytic leukaemia stage 4 Chronic lymphocytic leukaemia transformation Chronic myeloid leukaemia Chronic myeloid leukaemia transformation Chronic myelomonocytic leukaemia Coeliac disease Cold type haemolytic anaemia Colony stimulating factor therapy Colorectal cancer Combined immunodeficiency Condition aggravated Congenital anaemia Congenital anomaly Congenital aplastic anaemia Congenital cardiovascular anomaly Congenital dyserythropoietic anaemia Congenital dyskeratosis Cord blood transplant therapy Cryoglobulinaemia Cutaneous T-cell lymphoma Cutaneous lymphoma Cutaneous mucormycosis Cystinosis Cytogenetic abnormality Cytokine release syndrome Cytomegalovirus chorioretinitis Cytomegalovirus infection Cytomegalovirus infection reactivation Cytopenia DEMYELINATING POLYNEUROPATHY DESMOPLASTIC SMALL ROUND CELL TUMOUR DIFFUSE LARGE B-CELL LYMPHOMA DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA STAGE II DIFFUSE LARGE B-CELL LYMPHOMA STAGE III DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV DISEASE PROGRESSION DISEASE RECURRENCE DIZZINESS DONOR ORGAN TISSUE PREPARATION ISSUE DOUBLE HIT LYMPHOMA DRUG EXPOSURE DURING PREGNANCY DRUG THERAPY DRUG USE FOR UNKNOWN INDICATION Delayed graft function Delayed haemolytic transfusion reaction Diffuse large B-cell lymphoma Diffuse large B-cell lymphoma recurrent Diffuse large B-cell lymphoma refractory Diffuse large B-cell lymphoma stage II Diffuse large B-cell lymphoma stage III Diffuse large B-cell lymphoma stage IV Disease progression Disease recurrence Disseminated trichosporonosis Donor organ tissue preparation issue Double hit lymphoma Drug ineffective Drug therapy ENDOCRINE DISORDER ENTEROPATHY-ASSOCIATED T-CELL LYMPHOMA ENZYME LEVEL DECREASED EOSINOPHIL CATIONIC PROTEIN INCREASED EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER EPSTEIN-BARR VIRUS INFECTION EPSTEIN-BARR VIRUS INFECTION REACTIVATION ERYTHROLEUKAEMIA ESSENTIAL THROMBOCYTHAEMIA EWING'S SARCOMA EWING^S SARCOMA EX VIVO GENE THERAPY EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA (MALT TYPE) EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA (MALT TYPE) STAGE III Ejection fraction decreased Endometrial cancer Eosinophilia Eosinophilic colitis Epidermolysis bullosa Epstein-Barr virus associated lymphoproliferative disorder Epstein-Barr virus infection Epstein-Barr virus infection reactivation Essential thrombocythaemia Evans syndrome Evidence based treatment Extragonadal primary germ cell tumour Extranodal marginal zone B-cell lymphoma (MALT type) FAMILIAL HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS FLT3 gene mutation FOETAL EXPOSURE DURING PREGNANCY FOLLICLE CENTRE LYMPHOMA, FOLLICULAR GRADE I, II, III FOLLICLE CENTRE LYMPHOMA, FOLLICULAR GRADE I, II, III RECURRENT FOLLICLE CENTRE LYMPHOMA, FOLLICULAR GRADE I, II, III STAGE I FOLLICLE CENTRE LYMPHOMA, FOLLICULAR GRADE I, II, III STAGE II FOLLICLE CENTRE LYMPHOMA, FOLLICULAR GRADE I, II, III STAGE III FOLLICLE CENTRE LYMPHOMA, FOLLICULAR GRADE I, II, III STAGE IV FOLLICULAR B-CELL NON-HODGKIN^S LYMPHOMA FOLLICULAR LYMPHOMA FUNGAL INFECTION Familial haemophagocytic lymphohistiocytosis Fibrodysplasia ossificans progressiva Follicle centre lymphoma, follicular grade I, II, III Follicle centre lymphoma, follicular grade I, II, III stage III Follicle centre lymphoma, follicular grade I, II, III stage IV Follicular lymphoma Follicular lymphoma refractory Follicular lymphoma stage III Follicular lymphoma stage IV Forced expiratory volume decreased GASTRIC CANCER GASTROINTESTINAL LYMPHOMA GASTROINTESTINAL TOXICITY GATA2 deficiency GENE MUTATION GLIOBLASTOMA GLIOBLASTOMA MULTIFORME GRAFT VERSUS HOST DISEASE GRAFT VERSUS HOST DISEASE IN LUNG GRANULOMA Gastric cancer Gastrointestinal lymphoma Gatad2b associated neurodevelopmental disorder Gaucher^s disease type III Gene mutation Genotoxicity Glutaric acidaemia type I Graft infection Graft versus host disease Graft versus host disease in lung Graft versus host disease in skin Granulocyte percentage decreased Grey zone lymphoma Griscelli syndrome HAEMATOLOGICAL MALIGNANCY HAEMATOPOIETIC NEOPLASM HAEMATOPOIETIC STEM CELL MOBILISATION HAEMOGLOBIN HAEMOLYTIC ANAEMIA HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS HAIRY CELL LEUKAEMIA HEAVY CHAIN DISEASE HEPATOCELLULAR CARCINOMA HEPATOSPLENIC T-CELL LYMPHOMA HEPATOSPLENOMEGALY HEPATOTOXICITY HER2 negative breast cancer HIGH-GRADE B-CELL LYMPHOMA HISTIOCYTOSIS HAEMATOPHAGIC HISTOLOGY HODGKIN'S DISEASE HODGKIN^S DISEASE HODGKIN^S DISEASE NODULAR SCLEROSIS HODGKIN^S DISEASE STAGE II HODGKIN^S DISEASE STAGE IV HYPER IGE SYNDROME HYPERGAMMAGLOBULINAEMIA HYPOPHARYNGEAL CANCER HYPOPHOSPHATASIA Haematological malignancy Haematological neoplasm Haematopoietic stem cell mobilisation Haemophagocytic lymphohistiocytosis Hairy cell leukaemia Hepatic function abnormal Hepatoblastoma Hepatocellular carcinoma Hepatosplenic T-cell lymphoma High frequency ablation High grade B-cell lymphoma recurrent High-grade B-cell lymphoma Histiocytic sarcoma Hodgkin^s disease Hodgkin^s disease lymphocyte depletion type stage unspecified Hodgkin^s disease mixed cellularity stage unspecified Hodgkin^s disease nodular sclerosis Hodgkin^s disease nodular sclerosis stage III Hodgkin^s disease refractory Hormone-refractory prostate cancer Hyper IgE syndrome Hyper IgM syndrome Hyperkeratosis Hyperleukocytosis Hypertension Hypertrophic osteoarthropathy IDIOPATHIC THROMBOCYTOPENIC PURPURA ILL-DEFINED DISORDER IMMUNE SYSTEM DISORDER IMMUNE TOLERANCE INDUCTION IMMUNODEFICIENCY IMMUNODEFICIENCY COMMON VARIABLE IMMUNODEFICIENCY CONGENITAL IMMUNOMODULATORY THERAPY IMMUNOSUPPRESSANT DRUG THERAPY IMMUNOSUPPRESSION INFANTILE GENETIC AGRANULOCYTOSIS INFECTION INFECTION PROPHYLAXIS INFLAMMATORY BOWEL DISEASE INTERFERON GAMMA RECEPTOR DEFICIENCY INTESTINAL TRANSPLANT INTRAOCULAR MELANOMA INVASIVE DUCTAL BREAST CARCINOMA IPEX SYNDROME IPEX syndrome Idiopathic inflammatory myopathy Immune system disorder Immune tolerance induction Immune-mediated cytopenia Immunochemotherapy Immunodeficiency Immunomodulatory therapy Immunosuppressant drug therapy Immunosuppression Induction and maintenance of anaesthesia Infantile genetic agranulocytosis Infection Infection prophylaxis Inflammatory bowel disease Intentional product use issue Interferon gamma receptor deficiency Interstitial lung disease JUVENILE CHRONIC MYELOMONOCYTIC LEUKAEMIA JUVENILE IDIOPATHIC ARTHRITIS Juvenile chronic myelomonocytic leukaemia Juvenile idiopathic arthritis K-ras gene mutation KMT2A gene mutation KRABBE^S DISEASE Keratopathy Krabbe^s disease LANGERHANS' CELL HISTIOCYTOSIS LARGE GRANULAR LYMPHOCYTOSIS LEUKAEMIA LEUKAEMIA CUTIS LEUKAEMIA MONOCYTIC LEUKAEMIA RECURRENT LEUKAEMIC INFILTRATION EXTRAMEDULLARY LEUKAPHERESIS LEUKODYSTROPHY LIVER DISORDER LUNG ADENOCARCINOMA LUNG DISORDER LUNG NEOPLASM MALIGNANT LUNG SQUAMOUS CELL CARCINOMA METASTATIC LUPUS NEPHRITIS LYMPHADENITIS LYMPHADENOPATHY LYMPHOCYTE ADOPTIVE THERAPY LYMPHOCYTE COUNT ABNORMAL LYMPHOCYTE COUNT INCREASED LYMPHOCYTIC LEUKAEMIA LYMPHOCYTIC LYMPHOMA LYMPHOCYTOSIS LYMPHODEPLETION LYMPHOHISTIOCYTOSIS LYMPHOMA LYMPHOMA TRANSFORMATION LYMPHOPLASMACYTOID LYMPHOMA/IMMUNOCYTOMA LYMPHOPLASMACYTOID LYMPHOMA/IMMUNOCYTOMA REFRACTORY LYMPHOPLASMACYTOID LYMPHOMA/IMMUNOCYTOMA STAGE IV LYMPHOPROLIFERATIVE DISORDER Langerhans^ cell histiocytosis Large granular lymphocytosis Leukaemia Leukaemia cutis Leukaemia recurrent Leukocyte adhesion deficiency type I Leukodystrophy Leukoencephalopathy Lichen planus Light chain disease Lineage switch leukaemia Lung adenocarcinoma Lung adenocarcinoma stage IV Lung neoplasm malignant Lupus nephritis Lymphadenopathy Lymphocyte adoptive therapy Lymphocyte count abnormal Lymphocytic leukaemia Lymphocytic lymphoma Lymphodepletion Lymphoma Lymphoma transformation Lymphopenia Lymphoplasmacytoid lymphoma/immunocytoma Lymphoproliferative disorder Lysosomal acid lipase deficiency MALIGNANT LYMPHOID NEOPLASM MALIGNANT MELANOMA MALIGNANT NEOPLASM PROGRESSION MANTLE CELL LYMPHOMA MANTLE CELL LYMPHOMA RECURRENT MANTLE CELL LYMPHOMA REFRACTORY MANTLE CELL LYMPHOMA STAGE III MANTLE CELL LYMPHOMA STAGE IV MARGINAL ZONE LYMPHOMA MDS MEDICAL PROCEDURE MEDULLOBLASTOMA METACHROMATIC LEUKODYSTROPHY METASTASES TO BONE MARROW METASTASES TO CENTRAL NERVOUS SYSTEM METASTASES TO LUNG METASTASES TO LYMPH NODES METASTASES TO MENINGES METASTASES TO SPINE METASTASIS METASTATIC MALIGNANT MELANOMA METASTATIC MELANOMA METASTATIC NEOPLASM METASTATIC RENAL CELL CARCINOMA MISMATCHED DONOR BONE MARROW TRANSPLANTATION THERAPY MONOCLONAL GAMMOPATHY MONOCYTE COUNT DECREASED MONOCYTOPENIA MUCOPOLYSACCHARIDOSIS I MUCORMYCOSIS MULTIPLE MYELOMA MULTIPLE SCLEROSIS MYCOSIS FUNGOIDES MYCOSIS FUNGOIDES STAGE III MYELOBLAST PRESENT MYELODYSPLASTIC SYNDROME MYELODYSPLASTIC SYNDROME TRANSFORMATION MYELODYSPLASTIC SYNDROME UNCLASSIFIABLE MYELOFIBROSIS MYELOID LEUKAEMIA MYELOPROLIFERATIVE DISORDER MYELOPROLIFERATIVE NEOPLASM MYELOSUPPRESSION MYH9-related disease MYOSITIS Malignant fibrous histiocytoma Malignant lymphoid neoplasm Malignant melanoma Malignant melanoma stage III Malignant neoplasm progression Mantle cell lymphoma Mantle cell lymphoma refractory Mantle cell lymphoma stage III Mantle cell lymphoma stage IV Marginal zone lymphoma Marginal zone lymphoma stage IV McLeod neuroacanthocytosis syndrome Mediastinal mass Medical procedure Medulloblastoma Mesothelioma Mesothelioma malignant Metachromatic leukodystrophy Metastases to bone Metastases to central nervous system Metastases to lung Metastases to lymph nodes Metastases to skin Metastasis Metastatic malignant melanoma Metastatic neoplasm Metastatic renal cell carcinoma Minimal residual disease Monoclonal B-cell lymphocytosis Mucopolysaccharidosis I Mucopolysaccharidosis VII Multiple sclerosis Muscular weakness Mycobacterial infection Myeloblastoma Myelodysplastic syndrome Myelodysplastic syndrome transformation Myelodysplastic syndrome unclassifiable Myelodysplastic syndrome with excess blasts Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndrome Myelofibrosis Myeloid leukaemia Myeloproliferative neoplasm Myelosuppression Myositis Myxoid liposarcoma NATURAL KILLER CELL COUNT DECREASED NATURAL KILLER-CELL LEUKAEMIA NEOPLASM NEOPLASM MALIGNANT NEOPLASM PROGRESSION NERVOUS SYSTEM DISORDER NEUROBLASTOMA NEUROBLASTOMA RECURRENT NEUROFIBROMATOSIS NEUROPATHY PERIPHERAL NODAL MARGINAL ZONE B-CELL LYMPHOMA NODULAR (FOLLICULAR) LYMPHOMA NON-HODGKIN'S LYMPHOMA NON-HODGKIN'S LYMPHOMA RECURRENT NON-HODGKIN'S LYMPHOMA STAGE IV NON-HODGKIN'S LYMPHOMA UNSPECIFIED HISTOLOGY INDOLENT NON-HODGKIN'S LYMPHOMA UNSPECIFIED HISTOLOGY INDOLENT STAGE II NON-HODGKIN'S LYMPHOMA UNSPECIFIED HISTOLOGY INDOLENT STAGE IV NON-HODGKIN^S LYMPHOMA NON-HODGKIN^S LYMPHOMA RECURRENT NON-HODGKIN^S LYMPHOMA STAGE II NON-HODGKIN^S LYMPHOMA STAGE III NON-HODGKIN^S LYMPHOMA STAGE IV NON-HODGKIN^S LYMPHOMA UNSPECIFIED HISTOLOGY INDOLENT NON-SMALL CELL LUNG CANCER Natural killer cell activity abnormal Natural killer cell count decreased Natural killer-cell leukaemia Neoplasm Neoplasm malignant Neoplasm progression Neuroblastoma Neuroblastoma recurrent Neutropenia Nijmegen breakage syndrome Nodal marginal zone B-cell lymphoma Non-Hodgkin^s lymphoma Non-Hodgkin^s lymphoma recurrent Non-Hodgkin^s lymphoma refractory Non-Hodgkin^s lymphoma stage IV Non-Hodgkin^s lymphoma unspecified histology indolent Non-small cell lung cancer Non-small cell lung cancer metastatic Non-small cell lung cancer stage IIIB OCULAR LYMPHOMA OESOPHAGEAL SQUAMOUS CELL CARCINOMA OFF LABEL USE OMENN SYNDROME ORAL CAVITY CANCER METASTATIC ORGAN TRANSPLANT OROPHARYNGEAL SQUAMOUS CELL CARCINOMA OSTEOPETROSIS OSTEOSARCOMA OVARIAN CANCER OVARIAN CANCER METASTATIC OVARIAN CANCER STAGE III OVARIAN CANCER STAGE IV Ocular lymphoma Oesophageal squamous cell carcinoma Off label use Organ transplant Oropharyngeal squamous cell carcinoma Osteopetrosis Osteosarcoma Ovarian cancer Ovarian cancer metastatic Ovarian cancer recurrent Ovarian cancer stage III Ovarian epithelial cancer PANCREATIC CANCER METASTATIC PANCREATIC CARCINOMA METASTATIC PANCYTOPENIA PARANEOPLASTIC PEMPHIGUS PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA PERIPHERAL MOTOR NEUROPATHY PERIPHERAL SENSORIMOTOR NEUROPATHY PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED REFRACTORY PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED STAGE III PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED STAGE IV PERIPHERAL VASCULAR DISORDER PERIPHERAL VENOUS DISEASE PHILADELPHIA CHROMOSOME NEGATIVE PHILADELPHIA CHROMOSOME POSITIVE PHILADELPHIA POSITIVE ACUTE LYMPHOCYTIC LEUKAEMIA PLASMA CELL LEUKAEMIA PLASMA CELL MYELOMA PLASMA CELL MYELOMA RECURRENT PLATELET STORAGE POOL DEFICIENCY POLYARTHRITIS POLYCYTHAEMIA VERA PORPHYRIA NON-ACUTE POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER PRECURSOR B-LYMPHOBLASTIC LYMPHOMA PRECURSOR B-LYMPHOBLASTIC LYMPHOMA RECURRENT PRECURSOR T-LYMPHOBLASTIC LYMPHOMA/LEUKAEMIA PRECURSOR T-LYMPHOBLASTIC LYMPHOMA/LEUKAEMIA REFRACTORY PRECURSOR T-LYMPHOBLASTIC LYMPHOMA/LEUKAEMIA STAGE IV PREMEDICATION PREOPERATIVE CARE PRIMARY IMMUNODEFICIENCY SYNDROME PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA PRIMARY MYELOFIBROSIS PROBIOTIC THERAPY PRODUCT USED FOR UNKNOWN INDICATION PROLYMPHOCYTIC LEUKAEMIA PROPHYLACTIC CHEMOTHERAPY PROPHYLAXIS PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE PROPHYLAXIS AGAINST TRANSPLANT REJECTION PROSTATE CANCER PROSTATE CANCER METASTATIC PROSTATIC ADENOMA PSTPIP1-associated myeloid-related proteinaemia inflammatory syndrome PURINE METABOLISM DISORDER PYREXIA Pancreatic carcinoma Pancreatic carcinoma metastatic Pancytopenia Paraproteinaemia Parkinson^s disease Paroxysmal nocturnal haemoglobinuria Peripheral T-cell lymphoma unspecified Peripheral T-cell lymphoma unspecified stage III Peripheral blood stem cell apheresis Philadelphia chromosome negative Philadelphia chromosome positive Philadelphia positive acute lymphocytic leukaemia Philadelphia positive chronic myeloid leukaemia Plasma cell leukaemia Plasma cell myeloma Plasma cell myeloma recurrent Plasma cell myeloma refractory Pleural effusion Porphyria acute Post procedural complication Post transplant lymphoproliferative disorder Precursor B-lymphoblastic lymphoma Precursor B-lymphoblastic lymphoma refractory Precursor T-lymphoblastic leukaemia acute Precursor T-lymphoblastic lymphoma/leukaemia Precursor T-lymphoblastic lymphoma/leukaemia refractory Premedication Preoperative care Primary amyloidosis Primary immunodeficiency syndrome Primary mediastinal large B-cell lymphoma Primary myelofibrosis Product use in unapproved indication Product used for unknown indication Prolymphocytic leukaemia Prophylaxis Prophylaxis against graft versus host disease Prophylaxis against transplant rejection Prostate cancer Prostate cancer metastatic Protein deficiency Pulmonary sepsis Purine metabolism disorder Pyrexia REFRACTORY ANAEMIA REFRACTORY ANAEMIA WITH AN EXCESS OF BLASTS REFRACTORY CANCER REFRACTORY CYTOPENIA WITH MULTILINEAGE DYSPLASIA REFRACTORY CYTOPENIA WITH UNILINEAGE DYSPLASIA RENAL CELL CARCINOMA RENAL TRANSPLANT RHABDOMYOSARCOMA RICHTER^S SYNDROME Radiotherapy Rash Rash erythematous Refractory anaemia with an excess of blasts Renal cell carcinoma stage IV Renal impairment Renal tubular disorder Rhabdomyosarcoma Richter^s syndrome Round cell liposarcoma SALVAGE THERAPY SCLERODERMA SHWACHMAN-DIAMOND SYNDROME SICKLE CELL ANAEMIA SICKLE CELL DISEASE SIDEROBLASTIC ANAEMIA SKIN GRAFT SMALL CELL CARCINOMA SPLENIC MARGINAL ZONE LYMPHOMA SPLENIC MARGINAL ZONE LYMPHOMA STAGE IV SPLENOMEGALY SQUAMOUS CELL CARCINOMA OF HEAD AND NECK SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY STEM CELL THERAPY STEM CELL TRANSPLANT STILL^S DISEASE SURGICAL PRECONDITIONING SYNOVIAL SARCOMA METASTATIC SYNOVIAL SARCOMA RECURRENT SYSTEMIC LUPUS ERYTHEMATOSUS SYSTEMIC MASTOCYTOSIS SYSTEMIC SCLERODERMA SYSTEMIC SCLEROSIS Salvage therapy Scleroderma Second primary malignancy Shwachman-Diamond syndrome Sickle cell anaemia Sickle cell disease Skin graft Splenic marginal zone lymphoma Squamous cell carcinoma Squamous cell carcinoma of head and neck Squamous cell carcinoma of the oral cavity Stem cell donor Stem cell therapy Stem cell transplant Stiff person syndrome Still^s disease Subdural haematoma Superficial spreading melanoma stage unspecified Surgical preconditioning Symptomatic treatment Synovial sarcoma Synovial sarcoma metastatic Systemic lupus erythematosus Systemic mastocytosis Systemic scleroderma T-CELL CHRONIC LYMPHOCYTIC LEUKAEMIA T-CELL DEPLETION T-CELL LYMPHOMA T-CELL LYMPHOMA RECURRENT T-CELL LYMPHOMA REFRACTORY T-CELL LYMPHOMA STAGE I T-CELL LYMPHOMA STAGE IV T-CELL PROLYMPHOCYTIC LEUKAEMIA T-CELL TYPE ACUTE LEUKAEMIA T-cell lymphoma T-cell prolymphocytic leukaemia T-cell type acute leukaemia THALASSAEMIA THALASSAEMIA BETA THERAPEUTIC PROCEDURE THERAPY NAIVE THROMBOCYTOPENIA TP53 gene mutation TRANSPLANT TRANSPLANT FAILURE TRANSPLANT REJECTION TRISOMY 12 TRISOMY 21 Testicular disorder Thalassaemia Thalassaemia beta Therapeutic procedure Thrombocytopenia Transferrin decreased Transfusion Transplant Transplant failure Transplant rejection Triple negative breast cancer Tumour lysis syndrome UNEVALUABLE EVENT UNRELATED DONOR BONE MARROW TRANSPLANTATION THERAPY Unrelated donor bone marrow transplantation therapy Urinary bladder sarcoma VENOOCCLUSIVE LIVER DISEASE VERTIGO WALDENSTROM'S MACROGLOBULINAEMIA WALDENSTROM'S MACROGLOBULINAEMIA RECURRENT WALDENSTROM^S MACROGLOBULINAEMIA WEGENER'S GRANULOMATOSIS WHITE BLOOD CELL COUNT WHITE BLOOD CELL COUNT DECREASED WHITE BLOOD CELL DISORDER WISKOTT-ALDRICH SYNDROME Waldenstrom^s macroglobulinaemia White blood cell count decreased Wiskott-Aldrich syndrome X-LINKED CHROMOSOMAL DISORDER X-LINKED LYMPHOPROLIFERATIVE SYNDROME X-linked lymphoproliferative syndrome XANTHOGRANULOMA Fludarabine brand names and reporting trend
Fludarabine is sold under the brand name Oforta.
Quarterly reports (2004–2025) An upward trend reflects increased FAERS reporting overall, not necessarily increased risk.
Taking fludarabine with another medication? Ask OpenClaim about your specific drug combination. Get a sourced report using FDA data, drug labels, and medical literature.